Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Supernus Pharmaceuticals, Inc.

NASDAQ: SUPN · Life Sciences · 7 alerts · CIK 1356576

Share price
$28.83Close, Nov 16
Market cap
$1.68B
Shares outstanding
58.24MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Supernus Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:42 PM ET 8-K
Deal Termination

Supernus Pharmaceuticals Deal Termination with UBS Bank USA

Supernus Pharmaceuticals terminated its uncommitted demand revolving credit line with UBS Bank USA on October 20, 2026. The termination was made in anticipation of the company's pending merger with Indivior Pharmaceuticals and the establishment of a new senior secured credit facility for the combined entity. There were no outstanding borrowings or early termination penalties associated with the cancellation.

Counterparty
UBS Bank USA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.